PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Prothena Corporation plc (PRTA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

IE00B91XRN20

CUSIP

00B91XRN2

Sector

Healthcare

IPO Date

Dec 21, 2012

Highlights

Market Cap

$806.05M

EPS (TTM)

-$2.46

PEG Ratio

0.80

Total Revenue (TTM)

$133.03M

Gross Profit (TTM)

$74.64M

EBITDA (TTM)

-$89.22M

Year Range

$11.70 - $31.03

Target Price

$50.25

Short %

26.06%

Short Ratio

19.92

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Prothena Corporation plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-31.78%
9.31%
PRTA (Prothena Corporation plc)
Benchmark (^GSPC)

Returns By Period

Prothena Corporation plc had a return of 8.16% year-to-date (YTD) and -45.59% in the last 12 months. Over the past 10 years, Prothena Corporation plc had an annualized return of -5.60%, while the S&P 500 had an annualized return of 11.31%, indicating that Prothena Corporation plc did not perform as well as the benchmark.


PRTA

YTD

8.16%

1M

8.79%

6M

-31.79%

1Y

-45.59%

5Y*

4.77%

10Y*

-5.60%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of PRTA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.74%8.16%
2024-21.88%-2.82%-10.22%-17.88%2.31%-0.82%12.79%-4.34%-24.88%1.61%-4.65%-14.56%-61.89%
2023-6.14%-1.40%-13.07%8.56%26.24%2.78%0.86%-23.30%-8.65%-24.44%-10.64%11.54%-39.68%
2022-31.01%1.53%5.69%-20.26%-6.62%-0.29%14.40%-11.24%119.91%1.34%1.74%-3.62%21.96%
2021-6.66%99.11%12.54%5.65%9.91%76.24%-2.55%33.97%6.12%-22.29%-9.39%-1.50%311.32%
2020-23.12%-12.41%0.38%4.86%-4.99%-1.88%17.02%5.88%-22.92%9.21%3.76%6.10%-24.13%
201914.08%14.04%-9.48%-14.26%-10.38%13.41%-11.45%-10.15%-6.78%16.07%40.88%23.48%53.69%
201811.50%-19.40%8.96%-67.31%12.42%8.08%1.92%2.42%-14.06%-5.20%-3.15%-14.24%-72.53%
2017-0.47%19.79%-4.88%-2.98%-5.76%6.10%14.12%-0.52%5.42%-10.38%-19.91%-19.36%-23.79%
2016-42.81%-18.25%29.27%4.93%12.39%-27.98%57.47%-9.21%19.99%-20.26%23.42%-16.66%-27.78%
20159.01%17.45%43.49%-15.02%21.69%33.54%25.25%-12.79%-21.19%13.61%36.94%-3.44%228.08%
201416.67%16.39%6.39%-42.57%-5.36%8.31%-23.02%31.91%-3.23%-1.04%10.53%-14.36%-21.72%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PRTA is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PRTA is 1313
Overall Rank
The Sharpe Ratio Rank of PRTA is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of PRTA is 1313
Sortino Ratio Rank
The Omega Ratio Rank of PRTA is 1414
Omega Ratio Rank
The Calmar Ratio Rank of PRTA is 1414
Calmar Ratio Rank
The Martin Ratio Rank of PRTA is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Prothena Corporation plc (PRTA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PRTA, currently valued at -0.67, compared to the broader market-2.000.002.00-0.671.74
The chart of Sortino ratio for PRTA, currently valued at -0.85, compared to the broader market-4.00-2.000.002.004.006.00-0.852.35
The chart of Omega ratio for PRTA, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.32
The chart of Calmar ratio for PRTA, currently valued at -0.56, compared to the broader market0.002.004.006.00-0.562.61
The chart of Martin ratio for PRTA, currently valued at -1.27, compared to the broader market0.0010.0020.0030.00-1.2710.66
PRTA
^GSPC

The current Prothena Corporation plc Sharpe ratio is -0.67. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Prothena Corporation plc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.67
1.74
PRTA (Prothena Corporation plc)
Benchmark (^GSPC)

Dividends

Dividend History


Prothena Corporation plc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-81.01%
0
PRTA (Prothena Corporation plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Prothena Corporation plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Prothena Corporation plc was 90.85%, occurring on Aug 23, 2019. Recovery took 516 trading sessions.

The current Prothena Corporation plc drawdown is 81.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.85%Nov 30, 2015940Aug 23, 2019516Sep 10, 20211456
-84.85%Sep 24, 2021814Dec 18, 2024
-64.27%Mar 21, 201482Jul 17, 2014231Jun 17, 2015313
-36.96%Jul 29, 201554Oct 13, 201526Nov 18, 201580
-20.33%Jan 2, 201312Jan 17, 201355Apr 9, 201367

Volatility

Volatility Chart

The current Prothena Corporation plc volatility is 17.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
17.81%
3.07%
PRTA (Prothena Corporation plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Prothena Corporation plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Prothena Corporation plc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab